Premier (NASDAQ:PINC - Get Free Report) had its price target increased by research analysts at Piper Sandler from $19.00 to $24.00 in a report released on Wednesday,Benzinga reports. The firm currently has a "neutral" rating on the stock. Piper Sandler's target price would indicate a potential upside of 4.08% from the company's previous close.
PINC has been the subject of several other reports. Robert W. Baird boosted their target price on shares of Premier from $19.00 to $22.00 and gave the stock a "neutral" rating in a research report on Thursday, May 15th. Canaccord Genuity Group upped their price objective on shares of Premier from $19.00 to $22.00 and gave the stock a "hold" rating in a report on Thursday, May 8th. Seven research analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company presently has an average rating of "Hold" and an average target price of $22.20.
Check Out Our Latest Research Report on Premier
Premier Stock Performance
Shares of NASDAQ PINC traded down $0.14 during trading hours on Wednesday, hitting $23.06. The stock had a trading volume of 1,190,505 shares, compared to its average volume of 1,246,078. The firm's 50-day moving average price is $20.48 and its two-hundred day moving average price is $20.69. Premier has a 52 week low of $17.23 and a 52 week high of $23.56. The company has a market capitalization of $1.90 billion, a P/E ratio of -230.58 and a beta of 0.54.
Insider Transactions at Premier
In related news, General Counsel David L. Klatsky sold 10,000 shares of the firm's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $19.53, for a total value of $195,300.00. Following the transaction, the general counsel now directly owns 90,597 shares in the company, valued at approximately $1,769,359.41. This trade represents a 9.94% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Over the last three months, insiders sold 22,119 shares of company stock worth $464,974. 0.96% of the stock is owned by insiders.
Institutional Investors Weigh In On Premier
Several hedge funds and other institutional investors have recently made changes to their positions in the business. Van ECK Associates Corp lifted its position in shares of Premier by 28.0% during the 4th quarter. Van ECK Associates Corp now owns 2,041 shares of the company's stock worth $43,000 after purchasing an additional 446 shares during the last quarter. CW Advisors LLC increased its position in Premier by 1.8% in the 1st quarter. CW Advisors LLC now owns 26,166 shares of the company's stock worth $504,000 after buying an additional 454 shares during the period. SRS Capital Advisors Inc. increased its position in Premier by 157.8% in the 4th quarter. SRS Capital Advisors Inc. now owns 1,284 shares of the company's stock worth $27,000 after buying an additional 786 shares during the period. Baird Financial Group Inc. lifted its holdings in shares of Premier by 1.7% during the first quarter. Baird Financial Group Inc. now owns 56,826 shares of the company's stock worth $1,096,000 after buying an additional 972 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its position in shares of Premier by 40.4% in the fourth quarter. Russell Investments Group Ltd. now owns 4,371 shares of the company's stock valued at $93,000 after acquiring an additional 1,257 shares during the period. 74.41% of the stock is owned by institutional investors and hedge funds.
About Premier
(
Get Free Report)
Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.
Featured Articles
Before you consider Premier, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Premier wasn't on the list.
While Premier currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
